Literature DB >> 22426271

Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer.

Chang Hyun Kim1, Jung Wook Huh, Hun Jin Kim, Sang Woo Lim, Sang Yun Song, Hyeong Rok Kim, Kook Joo Na, Young Jin Kim.   

Abstract

BACKGROUND: The prognostic factors after pulmonary resection in patients with colorectal pulmonary metastases remain controversial.
OBJECTIVE: The study aimed to identify the predicting factors for oncological outcomes after curative resection in patients with colorectal cancer and pulmonary metastases.
DESIGN: This study is a retrospective review of prospectively collected data.
SETTING: This study was conducted at a tertiary care hospital/referral center in South Korea. PATIENTS: Between January 2000 and June 2010, 105 patients who developed pulmonary metastases after curative resection for colorectal cancer were enrolled. Forty-eight patients underwent pulmonary resection, and the remaining 58 were given chemotherapy and/or best supportive care. MAIN OUTCOME MEASURES: The primary outcomes measured were the predictive factors of survival and recurrence.
RESULTS: During the 35.9-month median follow-up period, 3- and 5-year overall survival rates were 54.6% and 30.4%. On multivariate analysis, absence of adjuvant chemotherapy after pulmonary metastases (p = 0.003), presence of extrapulmonary metastases (p = 0.001), elevated prelaparotomy serum CEA level (p = 0.015), and absence of pulmonary resection (p = 0.048) were independent prognostic factors for poor overall survival. In patients who underwent pulmonary resection, the 3-year pulmonary recurrence-free survival rate was 78.3%. On multivariate analysis, elevated prelaparotomy serum CEA level (p = 0.018) and disease-free interval ≤ 12 months (p = 0.008) were independent risk factors associated with pulmonary re-recurrence after pulmonary resection. LIMITATIONS: This study took place at a single institution and had a small sample size.
CONCLUSION: Although we admit, to some degree, the benefits of the selection mechanism, pulmonary metastasectomy from colorectal cancer may improve survival after curative resection of colorectal cancer. Adjuvant chemotherapy, extrapulmonary metastases, and prelaparotomy CEA value are independent prognostic factors for overall survival. Prelaparotomy serum CEA level may be an especially reliable predictor of both overall survival and recurrence-free survival after pulmonary metastasectomy in patients who undergo curative resection for colorectal cancer.

Entities:  

Mesh:

Year:  2012        PMID: 22426271     DOI: 10.1097/DCR.0b013e318246b08d

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  13 in total

1.  Impact of the post/preoperative serum CEA ratio on the survival of patients with rectal cancer.

Authors:  Tsukasa Hotta; Katsunari Takifuji; Shozo Yokoyama; Kenji Matsuda; Yoshimasa Oku; Toru Nasu; Junji Ieda; Naoyuki Yamamoto; Hiromitsu Iwamoto; Yoh Takei; Yuki Mizumoto; Hiroki Yamaue
Journal:  Surg Today       Date:  2014-02-07       Impact factor: 2.549

2.  Does adjuvant chemotherapy improve the prognosis of patients after resection of pulmonary metastasis from colorectal cancer? A systematic review and meta-analysis.

Authors:  Chao Zhang; Yuen Tan; Huimian Xu
Journal:  Int J Colorectal Dis       Date:  2019-08-24       Impact factor: 2.571

3.  Pulmonary metastasis in newly diagnosed colon-rectal cancer: a population-based nomogram study.

Authors:  Yiwei Huang; Mengnan Zhao; Jiacheng Yin; Tao Lu; Xiaodong Yang; Guangda Yuan; Ming Li; Yu Liu; Cheng Zhan; Qun Wang
Journal:  Int J Colorectal Dis       Date:  2019-03-11       Impact factor: 2.571

4.  Lung metastasectomy after colorectal cancer: prognostic impact of resection margin on long term survival, a retrospective cohort study.

Authors:  Federico Davini; Sara Ricciardi; Carmelina C Zirafa; Gaetano Romano; Greta Alì; Gabriella Fontanini; Franca M A Melfi
Journal:  Int J Colorectal Dis       Date:  2019-11-04       Impact factor: 2.571

5.  Preoperative carcinoembryonic antibody is predictive of distant metastasis in pathologically T1 colorectal cancer after radical surgery.

Authors:  Zheng Lou; Rong-Gui Meng; Wei Zhang; En-Da Yu; Chuan-Gang Fu
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

6.  Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

Authors:  Nedim Turan; Mustafa Benekli; Faysal Dane; Olcun Umit Unal; Hasan Volkan Kara; Dogan Koca; Ozlem Balvan; Tulay Eren; Didem Tastekin; Kaan Helvaci; Veli Berk; Umut Demirci; Selcuk Cemil Ozturk; Erkan Dogan; Bulent Cetin; Mehmet Kucukoner; Onder Tonyali; Gulnihal Tufan; Ilhan Oztop; Mahmut Gumus; Ugur Coskun; Aytug Uner; Ahmet Ozet; Suleyman Buyukberber
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

7.  Pulmonary Metastasectomy in Colorectal Cancer: has the randomized controlled trial brought enough reliable evidence to convince believers in metastasectomy to reconsider their oncological practice?

Authors:  Dirk Van Raemdonck; Tom Treasure; Eric Van Cutsem; Fergus Macbeth
Journal:  Eur J Cardiothorac Surg       Date:  2021-04-13       Impact factor: 4.191

Review 8.  Assessment of Overall Survival Benefits in Patients Undergoing Complete Hepatectomy for Synchronous Colorectal Cancer With Liver and Lung Metastases.

Authors:  Elsa Melissa Arvide; Jenilette Dames Velasco
Journal:  J Adv Pract Oncol       Date:  2016-11-01

Review 9.  Liver Resection in Patients With Synchronous Colorectal Liver and Lung Metastases.

Authors:  Allison Horner; Kendall Lencioni
Journal:  J Adv Pract Oncol       Date:  2016-11-01

10.  Emergency resection surgery for colorectal cancer: Patterns of recurrent disease and survival.

Authors:  Joe Littlechild; Muneer Junejo; Anne-Marie Simons; Finlay Curran; Darren Subar
Journal:  World J Gastrointest Pathophysiol       Date:  2018-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.